Literature DB >> 12712358

Plasma and whole-blood chemokine levels in patients with Behcet's disease.

Toshikatsu Kaburaki1, Yujiro Fujino, Hidetoshi Kawashima, Guillermo Merino, Jiro Numaga, Jun Chen, Kouji Matsushima.   

Abstract

BACKGROUND: Chemokines are a family of chemoattractants of leukocytes that play a critical role for leukocyte recruitment in various inflammatory diseases. The purpose of this study is to investigate the involvement of chemokines, interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) in the peripheral blood, with a special reference to disease activities of the patients with Behçet's disease (BD).
METHODS: The study population consisted of totally 55 patients with BD who had panuveitis (20 patients with active BD, 35 patients with inactive BD) as well as 19 healthy volunteers as control. Disease activity was defined according to the existence of ocular inflammation. IL-8 and MCP-1 concentration levels in the plasma and whole-blood samples were measured by enzyme-linked immunosorbent assay. Whole-blood samples were obtained by lysing cell membranes of peripheral blood cells.
RESULTS: Most of the plasma IL-8 samples were below the detectable limit. Whole-blood IL-8 levels were readily measured. The levels in the patients with active BD were significantly higher than the other two groups. The patients with active and inactive BD showed higher plasma and whole-blood levels of MCP-1 than controls. The plasma and whole-blood MCP-1 levels of the samples collected at the same time showed a linear correlation.
CONCLUSION: A close relationship was found to exist between the cell-associated IL-8 and the disease activity, while a persistent role of MCP-1 was observed in BD. Measuring the whole-blood levels of chemokines is useful for monitoring the disease activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12712358     DOI: 10.1007/s00417-003-0668-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  31 in total

Review 1.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

2.  Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis.

Authors:  T Yamamoto; B Eckes; K Hartmann; T Krieg
Journal:  J Dermatol Sci       Date:  2001-06       Impact factor: 4.563

3.  Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate.

Authors:  J Katsantonis; Y Adler; C E Orfanos; C C Zouboulis
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

4.  Reduced leukocyte migration, but normal rolling and arrest, in interleukin-8 receptor homologue knockout mice.

Authors:  M D Becker; L M O'Rourke; W S Blackman; S R Planck; J T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-06       Impact factor: 4.799

5.  Serum levels of interleukin-8 as a marker of disease activity in patients with chronic sarcoidosis.

Authors:  T Yokoyama; T Kanda; I Kobayashi; T Suzuki
Journal:  J Med       Date:  1995

6.  Autocrine regulation of interleukin-8 production in human monocytes.

Authors:  D D Browning; W C Diehl; M H Hsu; I U Schraufstatter; R D Ye
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-12       Impact factor: 5.464

7.  Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis.

Authors:  A M Klok; L Luyendijk; M J Zaal; A Rothova; C E Hack; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

8.  Enhanced interleukin 8 secretion in circulation of patients with Behçet's disease.

Authors:  A al-Dalaan; S al-Sedairy; S al-Balaa; M al-Janadi; K Elramahi; S Bahabri; S Siddiqui
Journal:  J Rheumatol       Date:  1995-05       Impact factor: 4.666

9.  Interleukin-6 (IL-6) in patients with Behçet's disease.

Authors:  Y Yamakawa; Y Sugita; T Nagatani; S Takahashi; T Yamakawa; S Tanaka; S Nakamura; S Ohno; H Sekihara; K Okuda; H Nakajima
Journal:  J Dermatol Sci       Date:  1996-03       Impact factor: 4.563

Review 10.  The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects.

Authors:  S Mishima; K Masuda; Y Izawa; M Mochizuki; K Namba
Journal:  Trans Am Ophthalmol Soc       Date:  1979
View more
  9 in total

1.  Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet's disease.

Authors:  Sho Ueda; Mitsuteru Akahoshi; Atsunobu Takeda; Yasushi Inoue; Aya Omoto; Masahiro Ayano; Yasutaka Kimoto; Hiroki Mitoma; Yojiro Arinobu; Hiroaki Niiro; Hiroshi Tsukamoto; Takahiko Horiuchi; Shin-Ichi Hikita; Takako Fukuhara; Tatsuro Ishibashi; Koh-Hei Sonoda; Koichi Akashi
Journal:  Eur J Rheumatol       Date:  2018-03

2.  Serum RANTES, MIP-1alpha, and MCP-1 levels in Behçet's disease.

Authors:  Huseyin T E Ozer; Eren Erken; Ramazan Gunesacar; Oguz Kara
Journal:  Rheumatol Int       Date:  2004-11-03       Impact factor: 2.631

3.  Visual aspects of Behçet's disease.

Authors:  Tulay Kansu; Sibel Kadayifcilar
Journal:  Curr Treat Options Neurol       Date:  2006-01       Impact factor: 3.598

Review 4.  The role of chemokines and their receptors in uveitis.

Authors:  Ahmed M Abu El-Asrar; Sofie Struyf; Ghislain Opdenakker; Karel Geboes; Jo Van Damme
Journal:  Int Ophthalmol       Date:  2007-03-13       Impact factor: 2.031

5.  Promoter -2518 single nucleotide polymorphism of monocyte chemoattractant protein-1 is associated with clinical severity in Behçet's disease.

Authors:  Seong-Kyu Kim; Won-Cheoul Jang; Young-Chang Ahn; Sang-Hyun Lee; Shin-Seok Lee; Jin-Wuk Hur
Journal:  Inflamm Res       Date:  2012-04-03       Impact factor: 4.575

6.  Colchicine modulates oxidative stress in serum and neutrophil of patients with Behçet disease through regulation of Ca²⁺ release and antioxidant system.

Authors:  Selma Korkmaz; Ijlal Erturan; Mustafa Nazıroğlu; Abdulhadi Cihangir Uğuz; Bilal Ciğ; Ishak Suat Övey
Journal:  J Membr Biol       Date:  2011-11-04       Impact factor: 1.843

Review 7.  Visual aspects of Behçet's disease.

Authors:  Tulay Kansu; Sibel Kadayifcilar
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

8.  Behcet's Disease With Cerebral Artery Infarction Caused by Cerebral Arteritis as an Early Symptom Only With Elevated Interleukin-8.

Authors:  Hao Yin; Yun Song; Meimei Zheng; Ju Han; Jiyou Tang
Journal:  Front Neurol       Date:  2019-10-22       Impact factor: 4.003

9.  Relationship between the higher inflammatory cytokines level in the aqueous humor of Fuchs uveitis syndrome and the presence of cataract.

Authors:  Hui Wang; Yong Tao
Journal:  BMC Ophthalmol       Date:  2021-02-27       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.